Nigel Rozario
Astellas Pharma (United States)
ORCID: 0000-0003-1510-1675Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Jason J. Schwartz, David Nimke, Mark Gallivan, Helene Fevrier, Nigel Rozario +2 more
Papers
Driven by 1 paper — median percentile 84. Top paper: “Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry”.
Jason J. Schwartz, David Nimke, Mark Gallivan, Helene Fevrier, Nigel Rozario +2 more